APLUSA

Helping you understand the evolving treatment landscape in Breast Cancer

HER2+ Metastatic Breast Cancer

Breast  cancer is a critical health issue affecting millions of women worldwide. October is Breast Cancer Awareness Month, dedicated to raising awareness, sharing experiences, and promoting research and prevention efforts. 

For almost 40 years, more and more stakeholders have been working to make October the month of breast cancer awareness. This period is an opportunity to communicate, exchange, and share experiences about breast cancer among health professionals. It is essential to discuss early detection, treatments, and patient experiences to improve outcomes and support people globally.

Understanding the epidemiology of breast cancer is crucial for awareness, prevention and treatment efforts. With 2.3 million new cases diagnosed per year1, Breast cancer is the second most common type of cancer worldwide, after Lung, and first in Europe. Among women, breast cancer is the most common type of cancer, with 666K deaths each year worldwide1, however, thanks to early detection, improvement in treatments and treatment management, breast cancer mortality is reducing at a rate of 2-4% per year2

Post ASH 23 webinar with Dr. Blin | Focus on DLBCL session

AplusA News, hemato-oncology, ASH, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...

Post ASH 23 webinar with Dr. Blin | Focus on MDS session

hemato-oncology, ASH, congress, MDS

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN with Dr. BLIN, provides...

Post ASH 23 webinar with Dr. Blin | Focus on MM session

AplusA News, hemato-oncology, Syndicated Studies, ASH, hematology, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...

Post ASH 23 webinar with Dr. Blin | Focus on AML session

AplusA News, hemato-oncology, ASH, hematology, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, providing comprehensive...

Etude d'impact sur la vaccination antigrippale pour Sanofi

vaccine

Notre étude APLUSA révèle l’impact qu’aurait une recommandation des autorités en faveur d’un vaccin...

💉 APLUSA Vaccine Expertise presented by William MacGILLIVRAY

Syndicated Studies, vaccine

AplusA ensures you are up-to-date with the latest vaccine market developments.

Over 30 years,...

SMML #6 ASCO & EHA 2023: POST-CONGRESS FOCUS

Digital, hemato-oncology

The goal of this newsletter is to give an overview of what is happening around multiple myeloma in ...

APLUSA and Dr. Nicolas BLIN presented multiple myeloma poster during EHA 2023 in Frankfurt

hematology, congress, EHA 2023

The European Hematology Association (EHA) congress was held in Frankfurt, Germany, on June 8, and...

SMML #5 Focus on past and upcoming congresses and conferences

Digital, hemato-oncology

The goal of this newsletter is to give an overview of what is happening around multiple myeloma in ...